Advicenne Pharma-Product Pipeline Review-2015

Advicenne Pharma-Product Pipeline Review-2015

  • Products Id :- GMDHC07429CDB
  • |
  • Pages: 32
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Advicenne Pharma-Product Pipeline Review-2015


Global Markets Direct's, 'Advicenne Pharma-Product Pipeline Review-2015', provides an overview of the Advicenne Pharma's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Advicenne Pharma's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


The report provides brief overview of Advicenne Pharma including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Advicenne Pharma's human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Advicenne Pharma's pipeline products

Reasons To Buy

Evaluate Advicenne Pharma's strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Advicenne Pharma in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Advicenne Pharma's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Advicenne Pharma and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Advicenne Pharma

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Advicenne Pharma and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Advicenne Pharma Snapshot 5

Advicenne Pharma Overview 5

Key Information 5

Key Facts 5

Advicenne Pharma-Research and Development Overview 6

Key Therapeutic Areas 6

Advicenne Pharma-Pipeline Review 8

Pipeline Products by Stage of Development 8

Pipeline Products-Monotherapy 9

Pipeline Products-Combination Treatment Modalities 10

Pipeline Products-Partnered Products 11

Partnered Products/Combination Treatment Modalities 12

Advicenne Pharma-Pipeline Products Glance 13

Advicenne Pharma-Late Stage Pipeline Products 13

Pre-Registration Products/Combination Treatment Modalities 13

Advicenne Pharma-Clinical Stage Pipeline Products 14

Phase II Products/Combination Treatment Modalities 14

Phase I Products/Combination Treatment Modalities 15

Advicenne Pharma-Early Stage Pipeline Products 16

Preclinical Products/Combination Treatment Modalities 16

Advicenne Pharma-Drug Profiles 17

ADV-6209 17

Product Description 17

Mechanism of Action 17

R&D Progress 17

clobazam 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

levetiracetam 19

Product Description 19

Mechanism of Action 19

R&D Progress 19

(potassium citrate + potassium bicarbonate) 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

ADV-7809 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

ADV-6208 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

ADV-6770 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

tetrabenazine 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

Advicenne Pharma-Pipeline Analysis 25

Advicenne Pharma-Pipeline Products by Target 25

Advicenne Pharma-Pipeline Products by Route of Administration 26

Advicenne Pharma-Pipeline Products by Molecule Type 27

Advicenne Pharma-Pipeline Products by Mechanism of Action 28

Advicenne Pharma-Dormant Projects 29

Advicenne Pharma-Locations And Subsidiaries 30

Head Office 30

Other Locations & Subsidiaries 30

Appendix 31

Methodology 31

Coverage 31

Secondary Research 31

Primary Research 31

Expert Panel Validation 31

Contact Us 31

Disclaimer 32

List of Tables

Advicenne Pharma, Key Information 5

Advicenne Pharma, Key Facts 5

Advicenne Pharma-Pipeline by Indication, 2015 7

Advicenne Pharma-Pipeline by Stage of Development, 2015 8

Advicenne Pharma-Monotherapy Products in Pipeline, 2015 9

Advicenne Pharma-Combination Treatment Modalities in Pipeline, 2015 10

Advicenne Pharma-Partnered Products in Pipeline, 2015 11

Advicenne Pharma-Partnered Products/ Combination Treatment Modalities, 2015 12

Advicenne Pharma-Pre-Registration, 2015 13

Advicenne Pharma-Phase II, 2015 14

Advicenne Pharma-Phase I, 2015 15

Advicenne Pharma-Preclinical, 2015 16

Advicenne Pharma-Pipeline by Target, 2015 25

Advicenne Pharma-Pipeline by Route of Administration, 2015 26

Advicenne Pharma-Pipeline by Molecule Type, 2015 27

Advicenne Pharma-Pipeline Products by Mechanism of Action, 2015 28

Advicenne Pharma-Dormant Developmental Projects,2015 29

Advicenne Pharma, Other Locations 30

List of Figures

Advicenne Pharma-Pipeline by Top 10 Indication, 2015 7

Advicenne Pharma-Pipeline by Stage of Development, 2015 8

Advicenne Pharma-Monotherapy Products in Pipeline, 2015 9

Advicenne Pharma-Pipeline by Top 10 Target, 2015 25

Advicenne Pharma-Pipeline by Top 10 Route of Administration, 2015 26

Advicenne Pharma-Pipeline by Top 10 Molecule Type, 2015 27

Advicenne Pharma-Pipeline Products by Top 10 Mechanism of Action, 2015 28

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@]

Current R&D Portfolio of Advicenne Pharma; Advicenne Pharma - Key Therapeutics; Advicenne Pharma - Pipeline Overview and Promising Molecules; Advicenne Pharma - News; Advicenne Pharma - Latest Updates; Advicenne Pharma - Pipeline; Advicenne Pharma - Discontinued/Dormant Projects

select a license

Single User License
USD 1500 INR 97350
Site License
USD 3000 INR 194700
Corporate User License
USD 4500 INR 292050



The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...

Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

query [@]